Provided by Tiger Trade Technology Pte. Ltd.

BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS

374.47
+5.311.44%
Post-market: 374.470.00000.00%19:30 EDT
Volume:252.60K
Turnover:95.12M
Market Cap:42.69B
PE:67.00
High:379.48
Open:375.00
Low:374.37
Close:369.16
52wk High:385.22
52wk Low:253.95
Shares:114.00M
Float Shares:85.69M
Volume Ratio:0.59
T/O Rate:0.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.59
EPS(LYR):2.47
ROE:14.66%
ROA:7.46%
PB:8.25
PE(LYR):151.61

Loading ...

BeOne Medicines (ONC), What Is Behind The Fresh Attention Now?

Simply Wall St.
·
Aug 19

BeOne Medicines, Foundations Renew Deal to Deliver Cancer Medicine to Poor Countries

MT Newswires Live
·
Aug 18

Beone Medicines Rises 1.34% With H1 Revenue Reaching 22.2 Billion Yuan as Global Expansion Accelerates

Deep News
·
Aug 18

BeOne Medicines renews partnerships to expand access to Brukinsa in leukemia

TIPRANKS
·
Aug 18

BeOne Medicines (ONC) Secures Rights To Four RAS(ON) Inhibitors In Asia

Simply Wall St.
·
Aug 15

JPMorgan Chase & Co. Increases Stake in BEONE MEDICINES by Over 4.1 Million Shares at Approximately HKD 219.79 Each

Stock News
·
Aug 14

Beone Medicines Awards Over 40,000 Restricted Stock Units to Employees

Stock News
·
Aug 13

Pharmaceutical Rally Continues: Gan&Lee Pharmaceuticals Hits Limit-Up, Beone Medicines Logs 6-Day Winning Streak; Huabao Funds' HK Medical and Innovation Drug ETFs Rise for Third Consecutive Session

Deep News
·
Aug 11

Beone Medicines : Jefferies Raises Target Price to $395 from $388

THOMSON REUTERS
·
Aug 11

CICC Retains Outperform Rating on BeiGene (06160) with HKD 266 Price Target

Stock News
·
Aug 11

BEONE MEDICINES Surges Over 4% in Morning Trading on Strategic Partnership with Revolution Medicines to Accelerate RAS Drug Development

Stock News
·
Aug 11

BeOne Medicines partners with Revolution Medicines for clinical development

TIPRANKS
·
Aug 10

BOCOM International Lifts BEONE MEDICINES Price Target to HKD 276, Maintains Buy Rating

Stock News
·
Aug 10

Goldman Sachs Competitor Adjusts BeOne Medicines Target Upward, Bullish Ratings Maintained

Deep News
·
Aug 09

BEONE MEDICINES Confirms External CMO Supply for Baiyueda, All Processes On Schedule

Deep News
·
Aug 07

BEONE MEDICINES: Approximately 95% of Pancreatic Cancer Cases Show KRAS Mutation, Around 20% Exhibit MTAP Deletion, Enabling Easy Identification of Overlapping Patient Groups

Deep News
·
Aug 07

BEONE MEDICINES Reports BRUKINSA Captures Over Half of New CLL/SLL Patient Share

Deep News
·
Aug 07

Beigene's GPC3x4-1BB Candidate Moves From Phase 1 to a Potential Pivotal Phase 2 Study in About 19 Months

Deep News
·
Aug 07

BEONE MEDICINES Halts Initial KRAS Inhibitor Project but Remains Active in RAS Field

Deep News
·
Aug 07

BEONE MEDICINES Plans to Unveil Preliminary CEA ADC Findings for Non-Small Cell Lung Cancer, Including Both Squamous and Non-Squamous Cases

Deep News
·
Aug 07